News Story #17598
Respiratory
Read MorePosted by Clinical Lab Products | Oct 2, 2001 | Cancer, Miscellaneous |
Respiratory
Read MorePosted by Clinical Lab Products | May 2, 2001 | Cancer, Miscellaneous |
As researchers discover that more diseases have their basis in autoimmunity, the need for standardized testing becomes apparent. Testing for autoimmune diseases desperately needs to be standardized, according to Robert Lahita, M.D., Ph.D., chi
Read MorePosted by Clinical Lab Products | Apr 10, 2001 | Cancer, Miscellaneous |
Researchers at UCSD Cancer Center have obtained evidence that the common anticoagulant drug heparin diminishes metastasis of certain cancers in mice by interfering with interactions between platelets and specific molecules on tumor cell surfaces.
Read MorePosted by Clinical Lab Products | Oct 10, 2000 | Cancer, Miscellaneous |
Boston Biomedica unit launches C6 Lyme peptide ELISA BBI Clinical Laboratories of New Britain, Conn., a subsidiary of Boston Biomedica of West Bridgewater, Mass., has launched a new antibody test for Lyme disease — the C6 Lyme Peptide ELISA (
Read MorePosted by Clinical Lab Products | Oct 1, 2000 | Cancer, Miscellaneous |
Oncology
Read More